Trial Details

TERMINATED
Basic Information
Clinical ID c4006
Identifier NCT01190839
Trial Title A Multicenter Trial Comparing REMICADE (Infliximab) and Placebo in the Prevention of Recurrence in Crohn's Disease (CD) Patients Undergoing Surgical Resection Who Are at an Increased Risk of Recurrence
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions BIOLOGICAL: Infliximab|DRUG: Placebo
Participant Information
Sponsor Janssen Biotech, Inc.
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2010-11
Primary Completion Date 2014-12
Completion Date 2014-12